Periodic Reporting for period 1 - WiNerve (Wireless Surgical Nerve Monitoring System)
Reporting period: 2017-12-01 to 2018-05-31
The opportunity explored in this Phase I project is the offering of novel wireless IOM, in which cables from nerve-hooked electrodes to the amplifier or stimulator are removed altogether. The safer connectivity afforded by RF links would eliminate the risk for cable swinging by the surgical team and the ensuing nerve damage.
The main objectives of this SME Phase I project were the achievement of an increase in our understanding of the market, our customers and competitors, and of the economics of the project. Overall we have confirmed the feasibility of the WiNerve business innovation and its potential for fast growth.
Moreover, the project has confirmed that a fully wireless IONM is considered by our market as desirable, innovative and at the forefront of the state of the art, and the attributes of a potentially successful new IONM product have been outlined.
In conclusion, as a result of the SME Phase I project Afferent Technologies has substantially increased its go-to-market focus. The work carried within phase I has set the foundations for substantial economic and societal impact and is guiding our next steps towards product launch. With increased knowledge-based confidence in the viability of the project we have concluded that WiNerve must be pursued further.